EE53 The Net Monetary Benefit of Introducing Sodium-Glucose Cotransporter-2 Inhibitors in Middle-Income Countries

Autor: M Falavigna, O Deyneli, A Seyam, N Mustafa, M Giorgi, Z Gabriel, S Goncalves, J Solorzano, H Vasnawala, V Schabert, J Mihajlović

Publikováno v: Value in Health. 25:S63

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d80d461ac7deb4d39b5b3080078937eb
https://doi.org/10.1016/j.jval.2022.09.306

A comparison of diabetes patient's self-reported health status with hemoglobin A1c test results in 11 California health plans

Autor: J, Wasserman, G, Boyce-Smith, D S, Hopkins, V, Schabert, M B, Davidson, R J, Ozminkowski, A, Albright, S, Kennedy

Publikováno v: Managed care (Langhorne, Pa.). 10(3)

To examine the relationship between hemoglobin A1c (HbA1c) test rates and values and various self-reported measures of health status within a sample of diabetes patients drawn from 11 California health plans, with a focus on improving diabetes care i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::584b06f87b76312089be628b88db2e94
https://pubmed.ncbi.nlm.nih.gov/11291499

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Treatment Patterns and Costs Of Neoadjuvant Systemic Therapies (NAT) For Early Breast Cancer (EBC): A Retrospective Claims Analysis.

Autor: Chen YJ; IMS Health, Alexandria, VA, USA., Santos E; Genentech, Inc., South San Francisco, CA, USA., Schabert V; IMS Health, Alexandria, VA, USA., Antao VP; Genentech, Inc., South San Francisco, CA, USA., De AP; IMS Health, Alexandria, VA, USA., Portera CC; Genentech, Inc., South San Francisco, CA, USA., Wang Y; IMS Health, Alexandria, VA, USA., Kamath T; Genentech, Inc., South San Francisco, CA, USA.

Publikováno v: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2014 Nov; Vol. 17 (7), pp. A655-6. Date of Electronic Publication: 2014 Oct 26.